BROLUCIZUMAB-DBLL for Polypoidal choroidal vasculopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 64 adverse event reports in the FDA FAERS database where BROLUCIZUMAB-DBLL was used for Polypoidal choroidal vasculopathy.
Most Reported Side Effects for BROLUCIZUMAB-DBLL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Vitreous floaters | 479 | 17.1% | 4 | 18 |
| Visual impairment | 446 | 15.9% | 1 | 28 |
| Vision blurred | 416 | 14.9% | 2 | 15 |
| Eye inflammation | 387 | 13.8% | 2 | 10 |
| Visual acuity reduced | 365 | 13.0% | 1 | 19 |
| Retinal vasculitis | 323 | 11.5% | 3 | 22 |
| Uveitis | 305 | 10.9% | 1 | 16 |
| Vitritis | 284 | 10.1% | 2 | 19 |
| Eye pain | 234 | 8.4% | 0 | 18 |
| Vitreous opacities | 205 | 7.3% | 1 | 15 |
| Anterior chamber cell | 199 | 7.1% | 2 | 15 |
| Blindness | 191 | 6.8% | 3 | 20 |
| Keratic precipitates | 183 | 6.5% | 1 | 8 |
| Death | 178 | 6.4% | 177 | 2 |
| Drug ineffective | 170 | 6.1% | 0 | 5 |
Other Indications for BROLUCIZUMAB-DBLL
Neovascular age-related macular degeneration (1,535)
Product used for unknown indication (583)
Age-related macular degeneration (445)
Choroidal neovascularisation (104)
Diabetic retinal oedema (60)
Macular degeneration (51)
Retinal vein occlusion (15)
Detachment of retinal pigment epithelium (8)
Diabetic retinopathy (7)
Retinal neovascularisation (7)
Other Drugs Used for Polypoidal choroidal vasculopathy
RANIBIZUMAB (315)
VERTEPORFIN (210)
AFLIBERCEPT (193)
BROLUCIZUMAB (70)
BEVACIZUMAB (46)
FARICIMAB\FARICIMAB-SVOA (43)
FLUOROURACIL (17)
IRINOTECAN (17)
LEUCOVORIN (17)
LUCENTIS (7)